Able Financial Group, LLC Haemonetics Corp Transaction History

Able Financial Group, LLC

  • $324 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$71.24 - $85.35 $122,675 - $146,972
1,722 Added 23.75%
8,973 $766 Million
Q4 2023

Jan 24, 2024
BUY
$80.59 - $92.61 $129,427 - $148,731
1,606 Added 28.45%
7,251 $620 Million
Q3 2023

Nov 07, 2023
BUY
$82.56 - $93.49 $466,051 - $527,751
5,645 New
5,645 $506 Million

Others Institutions Holding HAE

# of Institutions
334
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Able Financial Group, LLC Portfolio

Follow Able Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Able Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Able Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email